Kim described as a “shining light” by Dean Perlmutter Albert H. Kim, MD, PhD, neurosurgeon-scientist and Professor in the Departments of Neurosurgery, Genetics, Neurology, and Developmental Biology, was installed as the August A. Busch Jr. Professor of Neurological Surgery. A celebration to mark the event took place on Tuesday, Nov. 4 at the Jeffrey T. […]
Albert H. Kim MD, PhD
August A. Busch Jr. Professor of Neurological Surgery
Senior Vice-Chair, Department of Neurosurgery
Professor of Neurosurgery, Genetics, Neurology, and Developmental Biology
Director, Brain Tumor Center
Co-Leader, Neurorestorative Therapy Group, Hope Center
Castle Connolly Top Doctor
Kim and Limbrick awarded R01 grants with top scores
Obtaining a multi-million-dollar grant from the NIH is a wonderful accomplishment. Receiving a percentile score of 1% for a NIH grant is uncommon and is the equivalent to spotting a rare bird on the School of Medicine’s campus. This remarkable feat essentially means that the grant is near-perfect. WashU Neurosurgery is proud to announce that we have two rare birds amongst our […]
Kim named inaugural Danforth WashU Physician-Scientist Scholar
Neurosurgeon Albert H. Kim is a nationally recognized expert on brain tumors Albert H. Kim, MD, PhD, a professor of neurological surgery at Washington University School of Medicine in St. Louis, has been named the inaugural William H. Danforth Washington University Physician Scholar. He is the first researcher named as part of the School of […]
Kim Lab (Links to an external site)
Identify the molecular signals that control normal brain development and the abnormal signals that drive brain tumors.
Dacey receives the BJH Lifetime Achievement Award
On Nov. 14, 2024, Ralph G. Dacey, Jr., MD was honored for his thirty years of service to Barnes-Jewish Hospital and was awarded the BJH Lifetime Achievement “Master Physician” Award. Dr. Dacey was introduced by Chief of the Division of Spine Surgery Dr. Wilson Zachary Ray. To his peers, Dr. Dacey was regarded as one […]
Researchers make glioblastoma cells visible to attacking immune cells
Strategy involves placing targets on deadly cancer’s cells, potentially making them vulnerable to immunotherapies By: Julia Evangelou Strait Even treated with the most advanced therapies, patients with glioblastoma — an aggressive brain cancer — typically survive less than two years after diagnosis. Efforts to treat this cancer with the latest immunotherapies have been unsuccessful, likely […]
This is(n’t) Cancer: Advances Against Brain Tumors, Benign or Not
After minor blurred vision prompted Ellen to get an eye exam, she was surprised to learn she had a mass in the middle of her brain near the nerve connected to her left eye. A referral to Siteman quickly led to the diagnosis of a brain tumor. Fortunately, it was noncancerous and had a surgical […]
Study increases understanding of why recurrent meningiomas are aggressive
By: Graciela GutierrezArticle originally appeared in Baylor College of Medicine News Researchers at Baylor College of Medicine and Washington University School of Medicine in St. Louis have identified clinical and genetic predictors of multiply recurrent meningiomas (MRMs), a most aggressive form of this common brain tumor. Published in Science Advances, the study opens new opportunities for […]
Patel Named Surgical Director of Pituitary Center
Neurosurgeon Bhuvic Patel, MD, has been appointed surgical director of the Pituitary Center at Barnes-Jewish Hospital and Washington University School of Medicine in St. Louis. The center, part of The Brain Tumor Center at Siteman Cancer Center at Barnes-Jewish Hospital and WashU Medicine, provides multidisciplinary care for patients with tumors and other diseases that affect the pituitary gland and nearby […]